Woman Diagnosed With Ocular MG, Motor Neuropathy in Case Report
A woman was diagnosed with both ocular myasthenia gravis (MG) and a hereditary form of motor neuropathy, a condition…
Articles by Margarida Maia, PhD
#AAN2022 – Long-term Vyvgart Eases gMG Symptoms
Long-term treatment with Vyvgart (efgartigimod alfa-fcab) is safe and well tolerated, and leads to a sustained improvement in…
Better Surgery Outcomes Tied to More, Larger Thymus B-cell Clusters
More or larger clusters of developing B-cells, called germinal centers, in the thymus may predict better outcomes after thymus removal…
Yale Scientist Named MGNet Scholar Will Study MG Immune Mechanisms
This year’s MGNet Scholar award, funded by the Myasthenia Gravis Rare Disease Network (MGNet), has gone to a scientist…
‘Significant’ Healthcare Burden Evident With MG, Polish Study Finds
Nearly half of all people with myasthenia gravis (MG) in Poland were admitted…
Rozanolixizumab May Safely Ease Symptom Severity in gMG Patients
Rozanolixizumab, UCB’s investigational antibody, may ease symptom severity in adults with generalized myasthenia gravis (MG), and help them…
Diabetes May Be Immune System Trigger in MG, Worsening Symptoms
Diabetes, which causes blood sugar levels to rise abnormally, may trigger a stronger immune response and worsen myasthenia gravis…
Soliris May Be Safe, Effective for Rituximab-refractory gMG
Soliris (eculizumab) appears to be safe and effective for patients with hard-to-treat generalized myasthenia gravis (gMG) who have acetylcholine receptor…
Voice Issues May Be Sign of Late-onset MG, Case Report Shows
A 60-year-old man with dysphonia — voice issues when trying to speak — was found to have late-onset myasthenia…
Myasthenic Crisis During Sedation Leads to Diagnosis
A recent case report describes an elderly woman who was first diagnosed with myasthenia gravis (MG) after experiencing a…